 James Investment Research Inc. bought a new stake in shares of BioSpecifics Technologies Corp. NASDAQ:BSTC in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission SEC. The firm bought 4,960 shares of the biopharmaceutical companys stock, valued at approximately 281,000. James Investment Research Inc. owned approximately ... 